COVID19
Clinical trials for COVID19 explained in plain language.
Never miss a new study
Get alerted when new COVID19 trials appear
Sign up with your email to follow new studies for COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
COVID-19 drug study in kids halted early
Disease control TerminatedThis study aimed to see if the drug baricitinib is safe and works well for children aged 1 to 18 hospitalized with COVID-19. It planned to check how the drug moves through the body and if it reduces the need for breathing support. However, the study was stopped early after enroll…
Matched conditions: COVID19
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 16, 2026 20:18 UTC
-
New antibody drug tested against severe COVID-19 in hospital patients
Disease control TerminatedThis study tested an experimental antibody drug called SCTA01 in adults hospitalized with severe COVID-19. Participants received either the drug or a placebo to see if it helped them recover faster. The trial was stopped early, so results are limited.
Matched conditions: COVID19
Phase: PHASE2, PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Stem cell shot for COVID lungs put to the test
Disease control TerminatedThis study tested whether a single infusion of stem cells from donated umbilical cord tissue could help hospitalized adults with severe COVID-19 avoid needing a breathing tube or dying. Nineteen participants received either the stem cells or a placebo, plus standard care. The tri…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Ancient herbal remedy put to the test against COVID-19
Symptom relief TerminatedThis small pilot study tested whether a traditional Chinese medicine called Xuanfei Baidu granules is safe and acceptable for people with mild to moderate COVID-19. Only 10 adults were enrolled before the study was stopped early. The main goal was to see how many people would agr…
Matched conditions: COVID19
Phase: PHASE2 • Sponsor: Darcy Spicer • Aim: Symptom relief
Last updated Jun 10, 2026 13:28 UTC
-
New brain scanner peers into COVID's neurological mysteries
Knowledge-focused TerminatedThis pilot study tested a new brain PET-MR scanner to see if it can capture clear images of brain metabolism and blood flow in people who had COVID-19 and those who did not. Only 3 participants were enrolled before the study ended early. The goal was to develop an imaging protoco…
Matched conditions: COVID19
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 16, 2026 20:18 UTC
-
Smart vest monitors COVID patients
Knowledge-focused TerminatedThis study tested a special vest that tracks health data like heart rate and breathing in people hospitalized with COVID-19. The goal was to see if the vest could help doctors spot worsening symptoms early. Only 15 adults took part before the study ended early.
Matched conditions: COVID19
Sponsor: Nanowear Inc. • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC
-
COVID-19's hidden toll on the eye revealed
Knowledge-focused TerminatedThis study looked at whether COVID-19 can damage the retina, the light-sensitive part of the eye. Researchers used special cameras to take detailed pictures of the eyes of 23 people who had COVID-19. They compared those with severe illness to those with mild cases to see if the v…
Matched conditions: COVID19
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC
-
Arthritis drugs and COVID: do they weaken your defense?
Knowledge-focused TerminatedThis study looked at whether immunosuppressive medications used for rheumatoid arthritis or spondyloarthritis change how the body handles a COVID-19 infection. Researchers compared 150 patients on these drugs with infected family members not on such treatments. The goal was to me…
Matched conditions: COVID19
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
COVID chat tool tested, but study stopped early
Knowledge-focused TerminatedThis study tested a web-based guide to help people have conversations about COVID-19. Researchers wanted to see if the guide was helpful and easy to use. The study was stopped early and included 30 adults who spoke English or Spanish.
Matched conditions: COVID19
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC